Skip to Content
Merck
  • A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots.

A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots.

Chemical communications (Cambridge, England) (2012-05-01)
Oleg Kovtun, Emily J Ross, Ian D Tomlinson, Sandra J Rosenthal
ABSTRACT

Here we present the development and validation of a flow cytometry-based dopamine transporter (DAT) binding assay that uses antagonist-conjugated quantum dots (QDs). We anticipate that our QD-based assay is of immediate value to the high throughput screening of novel DAT modulators.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
GBR 12909 dihydrochloride, solid, ≥98% (HPLC)